[1]
|
S. B. Assidy and D. J. Driscoll, “Prader-Willi Syndrome,” European Journal of Human Genetics, Vol. 17, No. 1, 2009, pp. 3-13. doi:10.1038/ejhg.2008.165
|
[2]
|
R. D. Nicholls, S. Sautoh and B. Horsthemke, “Imprinting in Prader-Willi and Angelman Syndromes,” Trends in Genetics, Vol. 14, No. 5, 1998, pp. 194-200.
doi:10.1016/S0168-9525(98)01432-2
|
[3]
|
M. S. Wil-liams, B. L. Rooney, J. Williams, K. Josephson and R. Pauli, “Investigation of Thermoregulatory Characteristics in Patients with Prader-Willi Syndrome,” American Journal of Medical Genetics, Vol. 49, No. 3, 1994, pp. 302-307. doi:10.1002/ajmg.1320490312
|
[4]
|
L. Priano, G. Miscio, G. Grugni, E. Milano, S. Baudo, L. Sellitti, R. Picconi and A. Mauro, “On the Origin of Sensory Impairment and Altered Pain Perception in Prader-Willi Syndrome: A Nuerological Study,” European Journal of Pain, Vol. 13, No. 8, pp. 829-835.
doi:10.1016/j.ejpain.2008.09.011
|
[5]
|
V. A. Holm, S. B. Cassidy, M. G. Butler, J. M. Hanchett, L. R. Greenswag, B. Y. Whitman and F. Greenberg, “Prader-Willi Syndrome: Consensus Diagnostic Criteria,” Pediatrics, Vol. 91, No. 2, 1993, pp. 398-402
|
[6]
|
S. Stahl and M. Briley, “Understanding Pain in Depression,” Human Psychopharmacology, No. S1, 2004, pp. S19- S13.
|
[7]
|
A. I. Basbaum and H. L. Fields, “Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry,” Annual Review of Neuroscience, Vol. 7, 1984, pp. 309-338. doi:10.1146/annurev.ne.07.030184.001521
|
[8]
|
K. Nakai, A. Nakae, S. Aba, T. Mashimo and K. Ueda, “5-HT2C Receptor Agonists Attenuate Pain-Related Behaviour in a Rat Model of Trigeminal Neuropathic Pain,” European Journal of Pain, Vol. 14, No. 10, 2010, pp. 999-1006. doi:10.1016/j.ejpain.2010.04.008
|
[9]
|
C. M. Burns, H. Chu, S. M. Rueter, L. K. Hutchinson, H. Canton, E. Sander-Bush, R. B. Emeson, “Regulation of Serotonin-2C Receptor G-Protein Coupling by RNA Editing,” Nature, Vol. 387, No. 6630, 1997, pp. 303-308.
doi:10.1038/387303a0
|
[10]
|
C. M. Niswender, S. C. Copeland, K. Herrick-Davis, R. B. Emeson and E. Sander-Bush, “RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Consititutive Activity,” Journal of Biological Chemistry, Vol. 274, No. 14, 1999, pp. 9472-9478.
doi:10.1074/jbc.274.14.9472
|
[11]
|
Q. Wang, P. J. O’Brien, C. X. Chen, D. S. Cho, J. M., Murray and K. Nishikura, “Altered G Protein-Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin 2C Receptors,” Journal of Neurochemistry, Vol. 74, No. 3, 2000, pp. 1290-300.
doi:10.1046/j.1471-4159.2000.741290.x
|
[12]
|
I. Visiers, S. A. Hassan and H. Weinstein, “Differences in Conformational Properties of Second Intracellular Loop (IL2) in 5HT(2C) Receptors Modified by RNA Editing ca Account for G Protein Coupling Efficiency,” Protein Engineering, Vol. 14, No. 6, 2001, pp. 409-414.
doi:10.1093/protein/14.6.409
|
[13]
|
A. Nakae, K. Nakai, T. Tanaka, S. Hagihira, M. Shibata, K. Ueda and T. Mashimo “The Role of RNA Editing of the Serotonin 2C Receptor in a Rat Model of Oro-Facial Neuropathic Pain,” European Journal of Neuroscience, Vol. 27, No. 9, 2008, pp. 2373-2379.
doi:10.1111/j.1460-9568.2008.06205.x
|
[14]
|
A. Nakae, K. Nakai, T. Tanaka, M. Takashina, S. Hagihira, M. Shibata, K. Ueda and T. Mashimo, “Serotonin2C Receptor mRNA Editing in Neuropathic Pain Model,” Neuroscience Re-search, Vol. 60, No. 2, 2008, pp. 228- 231. doi:10.1016/j.neures.2007.10.004
|
[15]
|
K. Herrick-Davis, E. Grinde and C. M. Niswender, “Serotonin 5-HT2C Receptor RNA Editing Alters Receptor Basal Activity: Implications for Serotonergic Signal Transdaction,” Journal of Neurochemistry, Vol. 73, No. 4, 1999, pp. 1711-1717. doi:10.1046/j.1471-4159.1999.731711.x
|
[16]
|
R. Flomen, J. Knight, P. Sham, R. Kerwin and A. Makoff, “Evidence That RNA Editing modulates Splice Site Selection in the 5-HT2C Receptor Gene,” Nucleic Acids Research, Vol. 32, No. 7, 2004, pp. 2113-2122.
doi:10.1093/nar/gkh536
|
[17]
|
T. Kiss, “Small Nucleolar RNAs: An Abundant Group of Noncoding RNAs with Doverse Cellular Functions,” Cell, Vol. 109, No. 2, 2002, pp. 145-148.
doi:10.1016/S0092-8674(02)00718-3
|
[18]
|
C. M. Doe, D. Relkovic, A. S. Garfield, J. W. Dalley, D. E. Theobald, T. Humby, L. S. Wilkinson and A. R. Isles, “Loss of the Imprinted snoRNA mbii-52 Leads to Increased 5htr2c pre-RNA Editing and Altered 5HT2cR Mediated Behaviour,” Human Molecular Genetics, Vol. 18, No. 12, 2009, pp. 2140-2158.
doi:10.1093/hmg/ddp137
|
[19]
|
M. Zimmermann, “Ethical Guidelines for Investigations of Experimental Pain in Conscious Animals,” Pain, Vol. 16, No. 2, 1983, pp. 109-110.
doi:10.1016/0304-3959(83)90201-4
|
[20]
|
B. P. Vos, A. M. Strassman and R. J. Maciewicz, “Behavioral Evidence of Trigeminal Neuropathic Pain Following Chronic Constiriction Injury to the Rat’S Infraorbital Nerve,” J Neurosci , Vol. 14, 1994, pp. 2708-2723
|
[21]
|
G. J. Bennett and Y. K. Xie, “A Peripheral Mononeuropathy in Rat That Produces Disorders of Pain Sensation Like Those Seen in Man,” Pain , Vol. 33, No. 1, 1984, pp. 87-107. doi:10.1016/0304-3959(88)90209-6
|
[22]
|
S. Kishore, “The snoRNA HBII-52 Absent in Prader-Willi Syndrome Patients Regulates the Alternative Splicing of the Serotonin Receptor 5-HT2cR,” 1984.
http://www.stamms-labnet/pdfs/theses/Kishore_Thesis.pdf
|